Results of new research showing that COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients and prolonged ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

Approved targeted drugs for HER2 -mutant NSCLC include trastuzumab deruxtecan (T-DXd, Enhertu) -- which is highly effective ...

Ten years ago, my husband Sergio was diagnosed with advanced lung cancer at age 65. He refused the only treatment offered to ...

AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented new studies related to a range of cancer types at the ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

Natasha Loveridge's fight against terminal EFGR Positive lung cancer aims to keep her alive longer - and inspire new ...

The arrival of Ion Robotic Bronchoscopy at Adirondack Medical Center means surgeons can detect lung cancers in earlier, potentially more treatable stages. Patients may also recover more quickly from ...

Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by ...